Phase II trial data identified nausea, vomiting, diarrhoea, and dyspepsia as the most common GI side effects
In the UK, several GLP-1 receptor agonists are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA), each with specific indications: semaglutide (Ozempic for type 2 diabetes, Wegovy for weight management), dulaglutide (Trulicity for type 2 diabetes), and liraglutide (Victoza for type 2 diabetes, Saxenda for weight management)
18 19 GLP-1s also arent recommended for people with inflammatory bowel disease, gastroparesis, or a family history of thyroid cancer
Klinic will manage insurance verifications, prior authorization, and provide consistent care coordination, letting you focus on achieving your health aspirations in Berlin, Maryland